Harvey Singer Caught His Prostate Cancer Early. Here’s How.
Harvey Singer: Cancer recently struck the advocate of BRCA awareness for the third time. Image by Courtesy of Harvey Singer
When the Forward first wrote about Harvey Singer two years ago, he shared his trials of being diagnosed with breast cancer in 2008. The Rochester, New York, resident opted for a full mastectomy, only to be diagnosed with prostate cancer 18 months later. Recently, we learned that Singer faced yet another monumental health scare after we spoke with him in 2014.
Singer recalls that after taking several prostate-specific antigen (PSA) blood tests, which is the standard way to detect prostate cancer, he noted that his test results were steadily rising. Although a PSA test alone cannot confirm evidence of cancer, the higher a man’s PSA level, the more likely it is that he has prostate cancer, according to the National Cancer Institute. Moreover, a continuous rise in a man’s PSA level over time may also be a sign of prostate cancer.
“What should have been 0.0 was 0.01, 0.02, then 0.04 and 0.07,” recalled Singer, 62, of the test results.
Singer’s oncologist wanted to follow the standard protocol, which uses a PSA level of 0.2 as an indication that the cancer had returned, but Singer refused to sit on his hands. He had received genetic testing after his original prostate cancer diagnosis and found he was a BRCA2 carrier, which placed him at increased risk for an aggressive form of the disease.
Singer opted for 39 grueling treatments of radiation, and his PSA ultimately returned to an undetectable level a year and a half later. He is vigilant about monitoring for disease and continues to have blood tests every three months.
“What I tend to shout from the rooftops is that if you’re going through any of this cancer stuff, you have to be your own advocate,” Singer said.
He and his sister, Vicki, who is a three-time breast cancer survivor and also carries the BRCA2 defect, co-founded HIS Breast Cancer Awareness Foundation to fill the information void about the risk for men with BRCA mutations. Singer also shared his story in a book and recent film “Pink and Blue: Colors of Hereditary Cancer,” a documentary about male mutation carriers.
“You ask 20 guys if they carry the BRCA gene, probably 18 will tell you no because they don’t understand,” said Singer. “They think, oh, it’s a women’s genetic disposition, it’s not something for a man,” he added.
Karen Iris Tucker is a freelance journalist who writes primarily about health, genetics and cultural politics. Finder her work at kareniristucker.com and on Twitter @kareniristucker
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning journalism this Passover.
In this age of misinformation, our work is needed like never before. We report on the news that matters most to American Jews, driven by truth, not ideology.
At a time when newsrooms are closing or cutting back, the Forward has removed its paywall. That means for the first time in our 126-year history, Forward journalism is free to everyone, everywhere. With an ongoing war, rising antisemitism, and a flood of disinformation that may affect the upcoming election, we believe that free and open access to Jewish journalism is imperative.
Readers like you make it all possible. Right now, we’re in the middle of our Passover Pledge Drive and we still need 300 people to step up and make a gift to sustain our trustworthy, independent journalism.
Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly.
— Rachel Fishman Feddersen, Publisher and CEO
Join our mission to tell the Jewish story fully and fairly.
Only 300 more gifts needed by April 30
